Lee, Joo-Ryung
(Department of Nuclear Medicine, Kyungpook National University Hospital, Kyungpook National University Medical School)
Ahn, Byeong-Cheol (Department of Nuclear Medicine, Kyungpook National University Hospital, Kyungpook National University Medical School) Jeong, Shin-Young (Department of Nuclear Medicine, Kyungpook National University Hospital, Kyungpook National University Medical School) Lee, Jae-Tae (Department of Nuclear Medicine, Kyungpook National University Hospital, Kyungpook National University Medical School) Lee, Kyu-Bo (Department of Nuclear Medicine, Kyungpook National University Hospital, Kyungpook National University Medical School) |
1 | Shennan SI. Mangement of differentiated thyroid carcinoma. Korean J Endocrinol 2002;17(Supp-2):31-51 |
2 | Jeevanram RK, Shah DH, Sharma SM, Ganatra RD. Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients. Nucl Med Biol 1986;13:277-9 |
3 | Yamamoto Y, Nishiyama Y, Ono Y, Satoh K, Ohkawa M, Kawasaki Y et al. Accumulation of technetimn-99m pertechnetate in a patient with metastases of thyroid carcinoma. Ann Nucl Med 1999;13:357-9 |
4 | Mandel SJ, Shankar LK, Benard F, Yamamoto A, Alavi A Superiority of iodine-123 compared with iodine-l3l scanning for thyroid remnants in patients with differentiated thyroid cancer. Clin Nucl Med 2001;26:6-9 |
5 | Pacini F. Follow-up of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 2002;29(S-2):492-6 |
6 | Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996;37:598-605 |
7 | Moser E, Fritsch S, Broun S. Thyroglobulin and l31I uptake of remaining tissue in patients with differentiated carcinoma after thyroidectomy. Nuc1 Med Comm 1988;9:262-266 |
8 | Yoon SN, Park CH, Hwang KH, Kim S, Sho EY, Kim KR. The usefulness of diagnostic scan using technetium-99m pertechnetate scintigraphy prior to the first ablative radioiodine treatment in patients with well differentiated thyroid carcinoma: a comparative study with iodine-131. Korean J Nucl Med 2000;34:285-93 |
9 | Campbell CM, Khafagi FA. Insensitivity of Tc-99m pertechnetate for detecting metastasis of differentiated thyroid carcinoma. Clin Nucl Med 1990;5:1-4 |
10 | Hong SW. Radioiodine therapy for differentiated thyroid cancer. Korean J Nucl Med 2000;34:265-75 |
11 | Khammash NF, Halker RK, Abdel-Dayem HM The use of technetiurn99m pertechnetate in postoperative thyroid carcinoma. A comparative study with iodine-131. Clin Nucl Med 1988;13:17-22 |
12 | Verma N, Singh-Wadhwa S, Arvela OM Metastatic thyroid cancer visualized on technetium pertechnetate and iodine-131 scintigraphy. Clin Nuc1l Med 2002;27:610-1 |
13 | Park HM Stunned thyroid after high-dose I-131 imaging. Clin Nucl Med 1992;17:501-2 |
14 | Schlumberger M, Tubiana M, De Vathaire F, Hill C, Gardet P, Travagli JP, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986;63:960-7 |
15 | Bernier MO, Leenhardt L, Hoang C, AurengoA, Mary JY, Menegaux F, et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2001;86:1568-73 |
16 | Kinder BK. Well differentiated thyroid cancer. Curr Opin Oncol 2003;15:71-7 |
17 | Dietlein M, Moka D, Sehicha H Radioiodine therapy for thyroid cancer. In: Biersack ill, Grunwald F. Thyroid cancer. Berlin: Springer; 2001. p. 93-12010. Sweeney DC, Johnstem GS. Radioiodine therapyfor thyroid cancer. Endoclin Metabol Clin North Am 1995;24:803-39 |